Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Devidas N. Chaturbhuj"'
Autor:
Santosh Karade, Devidas N. Chaturbhuj, Sourav Sen, Rajneesh K. Joshi, Smita S. Kulkarni, Subramanian Shankar, Raman R. Gangakhedkar
Publikováno v:
International Journal of Infectious Diseases, Vol 66, Iss C, Pp 33-41 (2018)
Objective: The objective of this review was to assess the burden of HIV drug resistance mutations (DRM) in Indian adults exposed to first-line antiretroviral therapy (ART) as per national guidelines. Methods: An advanced search of the published liter
Externí odkaz:
https://doaj.org/article/1315e4fd28c040bf849a54554546a005
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-8 (2018)
ALG-2 interacting protein X (ALIX) links HIV-1 Gag to the components of ESCRT-III. HIV-1 engages the ALIX via its nucleocapsid and LYPXnL motif in p6. Overexpression of ALIX corrects the release defect of PTAP deleted HIV-1 via LYPXnL/ALIX pathway. H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::658b61ccbc02a11d059bc559a84eb60e
https://pubmed.ncbi.nlm.nih.gov/29891975
https://pubmed.ncbi.nlm.nih.gov/29891975
Autor:
Rajneesh K. Joshi, Sourav Sen, Raman R. Gangakhedkar, Santosh Karade, Subramanian Shankar, Smita Kulkarni, Devidas N. Chaturbhuj
Publikováno v:
International Journal of Infectious Diseases, Vol 66, Iss C, Pp 33-41 (2018)
Objective The objective of this review was to assess the burden of HIV drug resistance mutations (DRM) in Indian adults exposed to first-line antiretroviral therapy (ART) as per national guidelines. Methods An advanced search of the published literat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d08af7390f075a4c7f439584649fb759
https://pubmed.ncbi.nlm.nih.gov/29128646
https://pubmed.ncbi.nlm.nih.gov/29128646
Autor:
Srikanth Tripathy, Dipen Desai, Ramesh S. Paranjape, Smita Kulkarni, Nandini Makwana, Vanangamudi Murugesan, Seturam B. Katti, Rahul K. Suryawanshi, Devidas N. Chaturbhuj, Susan Idicula-Thomas, Archana Sonawani, Sushama Jadhav
Publikováno v:
Bioorganic chemistry. 71
Rapid emergence of drug resistance is crucial in management of HIV infection limiting implementation of efficacious drugs in the ART regimen. Designing new molecules against HIV drug resistant strains is utmost essential. Based on the anti-HIV-1 acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::292dc9974accdb261d1f09d477fe4957
https://pubmed.ncbi.nlm.nih.gov/28236450
https://pubmed.ncbi.nlm.nih.gov/28236450
Autor:
Renu Garg, Padmini Srikantiah, Smita R. Thorat, Sandhya Kabra, D. C. S. Reddy, S. Rajasekaran, S Kumar, Srikanth Tripathy, Alaka Deshpande, Nitin K. Hingankar, Sharda R. Datkar, P. S. Deshmukh, Smita Kulkarni, Suvarna Sane, Michael R. Jordan, Devidas N. Chaturbhuj, Ramesh S. Paranjape, C. Chandrasekar
Publikováno v:
Clinical Infectious Diseases. 54:S348-S354
Human immunodeficiency virus drug resistance (HIVDR) in cohorts of patients initiating antiretroviral therapy (ART) at clinics in Chennai and Mumbai, India, was assessed following World Health Organization (WHO) guidelines. Twelve months after ART in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::250c27a376abc3346bea710e4e99bc0e
https://doi.org/10.1093/cid/cis005
https://doi.org/10.1093/cid/cis005
Autor:
Devidas N. Chaturbhuj, Smita R. Thorat, Velura Chandrasekhar, Sharda R. Datkar, Dandu C.S. Reddy, Padmini Srikantiah, Renu Garg, Nitin K. Hingankar, Sandhya Kabra, Srikanth Tripathy, Partha Haldar, Ramesh S. Paranjape, Damodar Bachani, Rajasekhar Koppada
Publikováno v:
AIDS Research and Human Retroviruses. 27:1291-1297
The World Health Organizations HIV Drug Resistance (WHO HIVDR) Threshold survey method was used to assess transmitted HIVDR in newly diagnosed HIV-1-infected primigravida women attending the Prevention of Parent to Child Transmission (PPTCT) centers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aff085217d09b79f36c5faf29b60329a
https://doi.org/10.1089/aid.2011.0036
https://doi.org/10.1089/aid.2011.0036
Autor:
Srikanth Tripathy, Praveen Deshmukh, Amita Gupta, Girish N. Nadkarni, Sarah E. Hudelson, Nitin K. Hingankar, Maria M. James, Susan H. Eshleman, Ramesh S. Paranjape, Dattaray G. Saple, Devidas N. Chaturbhuj, Bijal Shah, Louise Walshe, Satish B. Vaidya
Publikováno v:
AIDS Research and Human Retroviruses. 26:25-31
HIV-infected patients receiving antiretroviral (ARV) therapy (ART) in India are not all adequately virally suppressed. We analyzed ARV drug resistance in adults receiving ART in three private clinics in Mumbai, India. HIV viral load was measured in 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc37d5a27c42450c01d8c912d9257a08
https://doi.org/10.1089/aid.2009.0102
https://doi.org/10.1089/aid.2009.0102
Autor:
Rabindra N. Mishra, Jaya Chakravarty, Pallav Narayan Singh, Amit Agarwal, Devidas N. Chaturbhuj, Shyam Sundar, Madhukar Rai, Ramesh S. Paranjape, Ankita Chourasia, Swarali N. Kurle, Srikanth Tripathy
Publikováno v:
BMC Infectious Diseases
Background The National AIDS Control Organization of India has been providing free second line antiretroviral therapy (ART) since 2008. This observational study reports the survival and virologic suppression of patients on second-line ART under progr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8b21b89614aba670a9319e398c46186
https://pubmed.ncbi.nlm.nih.gov/26572102
https://pubmed.ncbi.nlm.nih.gov/26572102
Autor:
Rakesh Gupta, Ramesh S. Paranjape, Devidas N. Chaturbhuj, Srikanth Tripathy, Mukesh Kumar, Sourav Sen
We report the presence of drug resistance mutations in 7.4% (2/27) of the treatment-naive, HIV-1-infected children in Pune, India, who had HIV-1 RNA levels1,000 copies/ml. Nonnucleoside reverse transcriptase inhibitor (NNRTI) mutations, namely A98G a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cef34f8885b5533b10aa2b357d3b2e2
https://europepmc.org/articles/PMC3938931/
https://europepmc.org/articles/PMC3938931/
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e87441 (2014)
PLoS ONE
PLoS ONE
OBJECTIVES: Validation of a cost effective in-house method for HIV-1 drug resistance genotyping using plasma samples. DESIGN: The validation includes the establishment of analytical performance characteristics such as accuracy, reproducibility, preci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0759b19e3cbd918a54a4b9a89d2ce724
http://europepmc.org/articles/PMC3922725?pdf=render
http://europepmc.org/articles/PMC3922725?pdf=render